Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands.
Vaccine. 2021 Oct 29;39(45):6671-6681. doi: 10.1016/j.vaccine.2021.09.059. Epub 2021 Oct 9.
Universal mass vaccination (UMV) against rotavirus has been implemented in many but not all European countries. This study investigated the impact of UMV on rotavirus incidence trends by comparing European countries with UMV: Belgium, England/Wales and Germany versus countries without UMV: Denmark and the Netherlands.
For this observational retrospective cohort study, time series data (2001-2016) on rotavirus detections, meteorological factors and population demographics were collected. For each country, several meteorological and population factors were investigated as possible predictors of rotavirus incidence. The final set of predictors were incorporated in negative binomial models accounting for seasonality and serial autocorrelation, and time-varying incidence rate ratios (IRR) were calculated for each age group and country separately. The overall vaccination impact two years after vaccine implementation was estimated by pooling the results using a random effects meta-analyses. Independent t-tests were used to compare annual epidemics in the pre-vaccination and post-vaccination era to explore any changes in the timing of rotavirus epidemics.
The population size and several meteorological factors were predictors for the rotavirus epidemiology. Overall, we estimated a 42% (95%-CI 23;56%) reduction in rotavirus incidence attributable to UMV. Strongest reductions were observed for age-groups 0-, 1- and 2-years (IRR 0.47, 0.48 and 0.63, respectively). No herd effect induced by UMV in neighbouring countries was observed. In all UMV countries, the start and/or stop and corresponding peak of the rotavirus season was delayed by 4-7 weeks.
The introduction of rotavirus UMV resulted in an overall reduction of 42% in rotavirus incidence in Western European countries two years after vaccine introduction and caused a change in seasonal pattern. No herd effect induced by UMV neighbouring countries was observed for Denmark and the Netherlands.
轮状病毒普遍疫苗接种(UMV)已在许多欧洲国家实施,但并非所有国家都实施了该措施。本研究通过比较实施 UMV 的欧洲国家(比利时、英格兰/威尔士和德国)与未实施 UMV 的国家(丹麦和荷兰),调查了 UMV 对轮状病毒发病趋势的影响。
本观察性回顾性队列研究收集了 2001-2016 年期间轮状病毒检测、气象因素和人口统计学数据。为每个国家,研究了多个气象和人口因素作为轮状病毒发病率的可能预测因素。最终的预测因素纳入到负二项式模型中,以考虑季节性和序列自相关性,并分别计算每个年龄组和国家的时变发病率比值(IRR)。使用随机效应荟萃分析汇总结果,估算疫苗实施后两年的总体疫苗接种影响。使用独立 t 检验比较疫苗接种前和后时期的年度流行情况,以探索轮状病毒流行时间的任何变化。
人口规模和多个气象因素是轮状病毒流行病学的预测因素。总体而言,我们估计 UMV 可使轮状病毒发病率降低 42%(95%CI 23%;56%)。0-、1-和 2 岁年龄组的降幅最大(IRR 分别为 0.47、0.48 和 0.63)。未观察到 UMV 对邻国的群体效应。在所有 UMV 国家,轮状病毒季节的开始和/或停止以及相应的高峰期均延迟了 4-7 周。
在疫苗接种两年后,轮状病毒 UMV 的引入使西欧国家的轮状病毒总发病率降低了 42%,并改变了季节性模式。未观察到 UMV 邻国对丹麦和荷兰的群体效应。